SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-16-007014
Filing Date
2016-09-01
Accepted
2016-09-01 13:28:53
Documents
7
Period of Report
2016-09-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s104021_8k.htm 8-K 25369
2 EXHIBIT 1-1 s104021_ex1-1.htm EX-1.1 45061
3 EXHIBIT 4-1 s104021_ex4-1.htm EX-4.1 93496
4 EXHIBIT 5-1 s104021_ex5-1.htm EX-5.1 10056
5 EXHIBIT 10-1 s104021_ex10-1.htm EX-10.1 216796
6 EXHIBIT 99.1 s104021_ex99-1.htm EX-99.1 12810
7 GRAPHIC tex1-1logo.jpg GRAPHIC 18559
  Complete submission text file 0001615774-16-007014.txt   430576
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27072 | Film No.: 161865302
SIC: 2836 Biological Products, (No Diagnostic Substances)